DALLAS – The United States Medical Compression Alliance (USMCA) is working with Medtrade to offer additional information about the Lymphedema Treatment Act and what it means for the home medical equipment (HME) industry. USMCA represents the five main compression manufacturers: medi USA, Essity (parent company of the Jobst brand), Juzo, Lohmann & Rauscher and Sigvaris.
USMCA along with other stakeholders have worked with CMS to implement the Lymphedema Treatment Act (LTA), and their efforts will extend to private health insurers in the future. At Medtrade, several of these organizations will come together to co-present, including Carmen Anderson, USMCA representative; Sarah M. Bramblette, MSHL, Lymphedema Advocacy Group; Bill Lobosco, SunMED Medical and Noel Neil, ACU-Serve Corp.
TOPIC: Lymphedema Compression
WHEN: Wednesday, March 27 from 10:00 – 11:00
WHY: Product Categories To Consider
WHERE: Room D166
Attendees with a Conference Pass will learn about:
- The LTA—history and ongoing efforts from the Lymphedema Advocacy Group (LAG)
- The business side of compression, the call points, the customers, the patients and clinicians
- The US Medical Compression Alliance and the products the manufacturers provide
- The billing intricacies to be aware of with the new changes
The LTA is welcome news for the industry, but Heather Ferguson, founder of the LAG, points out that the legislation does have certain limitations.
“Many people assumed that the LTA would do additional things such as improve coverage for surgeries, pumps and other lymphedema-related treatment items or services,” she said. “These things were not and could not be included in the legislation, because benefit categories for those services and supplies already exist, so any modifications to coverage would need to be undertaken through regulatory action.”
